Your account is not claimed yet. You can sign up with ORCID to claim your account.

Helen T Chifotides

Years Active: 2020-2023
Publications (10 Years): 5

The University of Texas MD Anderson Cancer Center

National and Kapodistrian University of Athens (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Texas MD Anderson Cancer Center

United States

Senior Research Scientist

Education History

National and Kapodistrian University of Athens

Greece

PHD :: Chemistry, Bioinorganic

Publications

Helen T Chifotides, Srdan Verstovsek, Prithviraj Bose
Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments. Cancers 15 (13) (2023)
Helen T Chifotides, Prithviraj Bose, Srdan Verstovsek
Momelotinib: an emerging treatment for myelofibrosis patients with anemia. Journal of hematology & oncology 15 (1) (2022)
Siba El Hussein, Helen T Chifotides, Joseph D Khoury, Srdan Verstovsek, Beenu Thakral
Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update. Cancers 14 (14) (2022)
John O Mascarenhas, Hélène F E Gleitz, Helen T Chifotides, Claire N Harrison, Srdan Verstovsek, Alessandro Maria Vannucchi, Raajit K Rampal, Jean-Jacques Kiladjian, William Vainchenker, Ronald Hoffman, Rebekka K Schneider, Alan F List
Biological drivers of clinical phenotype in myelofibrosis. Leukemia (2022)
Helen T Chifotides, Prithviraj Bose, Srdan Verstovsek
Givinostat: an emerging treatment for polycythemia vera. Expert opinion on investigational drugs 29 (6) (2020)

Helen T Chifotides.css-eqlu8i{font-size:small;padding-left:4px;}